Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6640)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Dec 6, 2020 (publication date) through Apr 20, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Shimizu Y. Understanding the immunopathogenesis of COVID-19: Its implication for therapeutic strategy. World J Clin Cases 2020; 8(23): 5835-5843 [PMID: 33344582 DOI: 10.12998/wjcc.v8.i23.5835] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v8/i23/5835.htm |
| Number | Citing Articles |
| 1 |
J.L. Callejas Rubio, I. Aomar Millan, M. Moreno-Higueras, L. Martín Ripoll, E. Yuste Osorio, R. Ríos-Fernández. Caution with the use of dexamethasone in patients with COVID-19 in its initial phases. Revista Clínica Española (English Edition) 2021; 221(10): 592 doi: 10.1016/j.rceng.2021.02.005
|
| 2 |
Rana Farzi, Parisa Shiri Aghbash, Narges Eslami, Arezou Azadi, Ali Shamekh, Nima Hemmat, Taher Entezari-Maleki, Hossein Bannazadeh Baghi. The role of antigen-presenting cells in the pathogenesis of COVID-19. Pathology - Research and Practice 2022; 233: 153848 doi: 10.1016/j.prp.2022.153848
|
| 3 |
J.L. Callejas Rubio, I. Aomar Millan, M. Moreno-Higueras, L. Martín Ripoll, E. Yuste Osorio, R. Ríos-Fernández. Precaución con el uso de dexametasona en pacientes con COVID-19 en sus fases iniciales. Revista Clínica Española 2021; 221(10): 592 doi: 10.1016/j.rce.2021.02.001
|
| 4 |
Anolin Aslan, Cynthia Aslan, Naime Majidi Zolbanin, Reza Jafari. Acute respiratory distress syndrome in COVID-19: possible mechanisms and therapeutic management. Pneumonia 2021; 13(1) doi: 10.1186/s41479-021-00092-9
|
| 5 |
Vivek P. Chavda, Rajashri Bezbaruah, Sheetal Dolia, Nirav Shah, Sachin Verma, Shrinivas Savale, Suma Ray. Convalescent plasma (hyperimmune immunoglobulin) for COVID-19 management: An update. Process Biochemistry 2023; 127: 66 doi: 10.1016/j.procbio.2023.01.018
|
| 6 |
Angelica Perna, Eleonora Hay, Carmine Sellitto, Emiliano Del Genio, Maria De Falco, Germano Guerra, Antonio De Luca, Paolo De Blasiis, Angela Lucariello. Antiinflammatory Activities of Curcumin and Spirulina: Focus on Their Role against COVID-19. Journal of Dietary Supplements 2023; 20(2): 372 doi: 10.1080/19390211.2023.2173354
|
| 7 |
Yohei Takenaka, Ryu Tanaka, Kazuki Kitabatake, Kouji Kuramochi, Shin Aoki, Mitsutoshi Tsukimoto. Profiling Differential Effects of 5 Selective Serotonin Reuptake Inhibitors on TLRs-Dependent and -Independent IL-6 Production in Immune Cells Identifies Fluoxetine as Preferred Anti-Inflammatory Drug Candidate. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.874375
|
| 8 |
Thitikan Kunapaisal, Shuhong Guo, Courtney Gomez, Marie A Theard, John B Lynch, Abhijit V Lele, Mary A King, Robert Buckley, Monica S Vavilala. Bacterial Brain Abscess and Life-Threatening Intracranial Hypertension Requiring Emergent Decompressive Craniectomy After SARS-CoV-2 Infection in a Healthy Adolescent. Cureus 2023; doi: 10.7759/cureus.36258
|
| 9 |
Yaxian Yang, Liting Wang, Jingfang Liu, Songbo Fu, Liyuan Zhou, Yan Wang. Obesity or increased body mass index and the risk of severe outcomes in patients with COVID-19. Medicine 2022; 101(1): e28499 doi: 10.1097/MD.0000000000028499
|
| 10 |
Yan-Fei He, Zhi-Gang Jiang, Ni Wu, Ning Bian, Jun-Lin Ren. Correlation between COVID-19 and hepatitis B: A systematic review. World Journal of Gastroenterology 2022; 28(46): 6599-6618 doi: 10.3748/wjg.v28.i46.6599
|
| 11 |
Vivek P. Chavda, Normi Gajjar, Nirav Shah, Divyang J. Dave. Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment. European Journal of Medicinal Chemistry Reports 2021; 3: 100013 doi: 10.1016/j.ejmcr.2021.100013
|